In this webinar. Dr. Andrew Blakely, surgical oncologist, National Cancer Institute, Center for Cancer Research, NIH, discussed the basics of surgical removal of primary GISTs and considerations in multimetastatic disease.
Most GIST patients will see a surgeon at some point during their treatment. This webcast will address the issues surrounding the decision to have an operation and considers that surgical options depend on a number of factors such as tumor location, tumor size, tumor number, response to drug therapy, and risk of recurrence.
Charlie Burke has developed a thick skin when it comes to cancer. After surviving bouts with colorectal, thyroid and skin cancers, he was well acquainted with the routine of doctor’s appointments, hospital visits, surgeries and regular treatment that accompany disease by the time a GIST tumor was discovered in his colon. However, as any of our members will tell you, GIST comes with its own unique lexicon to master and set of challenges to overcome.
The results of a retrospective study indicated that patients with metastatic gastrointestinal stromal tumors (GIST) who are able to achieve complete macroscopic surgical resection of their disease may be able to achieve long-term survival.
A recent article in CureToday.com revealed a study that shows how mind-body surgery prep may reduce anxiety. Keep reading for more information!
Lon Garber It all began in Africa with a pain in my backside. My wife, Val, jokingly called it payback time since I’d been a pain in her backside for 37 years. The [...]
Dr. Ronald P. DeMatteo discusses surgery and molecular therapy for GIST in this webcast.